tobramycin has been researched along with cefotaxime in 129 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 57 (44.19) | 18.7374 |
1990's | 21 (16.28) | 18.2507 |
2000's | 35 (27.13) | 29.6817 |
2010's | 14 (10.85) | 24.3611 |
2020's | 2 (1.55) | 2.80 |
Authors | Studies |
---|---|
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Correa, A; Kattan, JN; Lolans, K; Lopez, JA; Quinn, JP; Villegas, MV | 1 |
Caniça, M; Ferreira, E; Leitão, J; Manageiro, V; Mendonça, N | 1 |
Bonomo, RA; Endimiani, A; Hujer, AM; Hujer, KM; Luzzaro, F; Mantengoli, E; Migliavacca, R; Pagani, L; Rossolini, GM; Toniolo, A | 1 |
Avlami, A; Daikos, GL; Katsilambros, N; Kosmidis, C; Petrikkos, G; Psychogiou, M; Stefanou, I; Tassios, PT; Vasilakopoulou, A | 1 |
Courvalin, P; Galimand, M; Périchon, B | 1 |
Beceiro, A; Bou, G; Canle, D; Fernández, A; Lasa, I; Latasa, C; Mallo, S; Molina, F; Pérez, A; Pérez, S; Poza, M; Tomás, Mdel M; Villanueva, R | 1 |
Liu, Y; Shi, W; Wang, M; Wu, S; Xu, X; Ye, X; Zhang, Y | 1 |
Adams-Haduch, JM; Doi, Y; Paterson, DL | 1 |
Chen, T; Khalil, H; Riffon, R; Wang, R; Wang, Z | 1 |
Arakawa, Y; Suzuki, S; Wachino, J; Yamane, K | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Espedido, BA; Iredell, JR; Partridge, SR | 1 |
Badur, S; Cagatay, AA; Carrër, A; Eraksoy, H; Nordmann, P; Poirel, L | 1 |
Bauernfeind, A; Keuleyan, E; Markovska, R; Queenan, AM; Rasshofer, R; Schneider, I | 1 |
Albertí, S; Beceiro, A; Bou, G; Garau, M; Gutiérrez, O; Juan, C; Oliver, A; Pérez, JL | 1 |
Cattoir, V; Nordmann, P; Poirel, L | 1 |
Berçot, B; Nordmann, P; Poirel, L | 1 |
Andlovic, A; Jeverica, S; Karisik, E; Koren, S; Krizan-Hergouth, V; Livermore, DM; Mesko Meglic, K; Müller-Premru, M; Palepou, MF; Pike, R; Seme, K; Woodford, N | 1 |
Baptista, BC; Correia, JD; da Fonseca, JD; Martínez-Martínez, L; Pomba, C | 1 |
Bradford, PA; Jones, CH; Keeney, D; Ruzin, A; Tuckman, M | 1 |
Bell, JM; Castanheira, M; Jones, RN; Mathai, D; Turnidge, JD | 1 |
Duljasz, W; Gniadkowski, M; Jebelean, C; Sitter, S; Wojna, A | 1 |
Gales, AC; Nordmann, P; Picão, RC; Poirel, L | 1 |
Choi, SH; Jeong, JY; Jun, JB; Kim, ES; Kim, MN; Kim, YS; Lee, SO; Woo, JH | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Carattoli, A; Ellington, MJ; Karisik, E; Livermore, DM; Underwood, A; Woodford, N | 1 |
Albertí, S; Bengoechea, JA; Doménech-Sánchez, A; Llobet, E; Martínez-Martínez, L; Padilla, E | 1 |
Courvalin, P; Coyne, S; Guigon, G; Périchon, B | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Dunman, PM; Hood, MI; Jacobs, AC; Sayood, K; Skaar, EP | 1 |
Beceiro, A; Bou, G; Doumith, M; Livermore, DM; Tomás, M; Turton, JF; Warner, M; Woodford, N | 1 |
Hamprecht, A; Higgins, PG; Schneiders, T; Seifert, H | 1 |
Maravić, A; Odžak, R; Skočibušić, M | 1 |
Kallfelz, HC; Oppermann-Paul, K; Paul, T; Peltner, HU | 1 |
Bryant, RE; Fox, K; Morthland, VH; Oh, G | 1 |
Armstrong, P; Blair, P; Lowry, K; Rowlands, BJ; Smilie, J; Webb, H | 1 |
Maiche, AG; Teerenhovi, L | 1 |
Francom, S; Jaimovich, DG; Kumar, A | 1 |
Ahnefeld, FW; Deller, A; Graf, B; Heeg, K; Kilian, J; Konrad, F | 1 |
Allington, DR; Chandler, MH; Pennell, AT | 1 |
Gamillscheg, A; Hauer, C; Lackner, H; Slavc, I; Urban, C | 1 |
Dehne, M; el Abed, K; Hofmann, W; Kroh, U; Lennartz, H | 1 |
Chastagner, P; Flamant, F; Hartmann, O; Kalifa, C; Lemerle, J; Patte, C; Tancrede, C | 1 |
Almirall, J; Montoliu, J; Ponz, E; Revert, L | 1 |
Ahnefeld, FW; Heeg, K; Kilian, J; Konrad, F; Schwalbe, B; Wagner, H; Wiedeck, H | 1 |
Alcock, SR; Parrott, DM; Speekenbrink, AB | 1 |
Grzeszczak, W; Kokot, F; Wiecek, A | 1 |
Banzer, S; Mondorf, A; Mondorf, W | 1 |
Broustet, A; Fourche, J; Leng, B; Marit, G; Pellegrin, JL; Reiffers, J; Texier-Maugein, J | 1 |
Weinstein, MP | 1 |
Bergeron, MG; Charest, A; Forcier, JF; LeBel, M; Morin, J; Vallée, F | 1 |
Holloway, JJ; Lietman, PS; Moore, RD; Smith, CR | 1 |
Hulstaert, PF; Kerver, AJ; Mevissen-Verhage, EA; Rommes, JH; Verhoef, J; Vos, A; Wittebol, P | 1 |
Adams, KR; Cierny, G; Mader, JT; Wilson, KJ | 1 |
Ardilouze, JL; Arich, C; Bengler, C; Dubois, A; Fabre, S; Gouby, A; Hansel, S; Janbon, C; Joubert, P | 1 |
Brunet, F; Dhainaut, JF; Dreyfus, F; Huyghebaert, MF; Lanore, JJ; Monsallier, JF; Varet, B | 1 |
Stoutenbeek, CP; van Saene, HK; Zandstra, DF | 1 |
Husson, MO; Izard, D; Leclerc, H | 2 |
Aoyama, H; Izawa, Y; Nishizaki, A; Okuda, J | 1 |
Chin, NX; Labthavikul, P; Neu, HC | 1 |
Lietman, PS; Moore, RD; Smith, CR | 2 |
Chin, NX; Labthavikul, P; Neu, HC; Saha, G | 1 |
Andrzejowska, H; Grzeszczak, W; Kokot, F; Wiecek, A | 1 |
Betzler, M; Geisen, HP; Schipplick, M; Schömig-Breckner, J | 1 |
Langrehr, D; Miranda, DR; Stoutenbeek, CP; van Saene, HK; Zandstra, DF | 1 |
Grassi, C | 1 |
Berk, SL | 1 |
Feshchenko, IuI; Molotkov, VN | 1 |
Bakken, JS; Hulsund, M | 1 |
Ali, RM; Beeching, NJ; Lang, SD; Shaw, DW | 1 |
Ambinder, R; Israel, E; Levitt, R; Lietman, PS; Lipsky, JJ; Longstreth, J; Mellits, ED; Petty, BG; Rocco, L; Smith, CR | 1 |
Bryskier, A; Husson, MO; Izard, D; Leclerc, H; Vincent, P | 1 |
Béland, L; Biron, S; Bourque, RA; Brochu, G; Marceau, P; Piché, P; Potvin, M | 1 |
Rahman, M | 1 |
Grötsch, H; Kuhlmann, J; Seidel, G | 1 |
Knothe, H | 1 |
Shah, PM; Stille, W; Troche, G | 1 |
Murray, PR | 1 |
Aznar, J; Iglesias, MC; Martin, E; Nogales, MC; Perea, EJ | 1 |
Daschner, FD; Schneider, H; Steffens, A | 1 |
Klastersky, J; Lagast, H; Zinner, SH | 1 |
Drew, WL; Mintz, L | 1 |
Fass, RJ | 1 |
Bailey, D; Feld, R; Fong, I; Harding, G; Mandell, L; Rachlis, A; Vincelette, J | 1 |
Neu, HC | 1 |
Canawati, HN; Gilmore, DS; Jiminez, EM; Malik, GM; Montgomerie, JZ; Morrow, JW | 1 |
Duma, RJ | 1 |
Ashley, MA; Kim, C; Montgomerie, JZ; Schick, DG | 1 |
Baer, DM; Horner, W; Jones, RN; Mullooly, JP | 1 |
Asphaug Kjellevold, V; Dibb, WL; Digranes, A | 1 |
Watanakunakorn, C | 1 |
Fleming, PJ; Hawkey, PM; Lewis, DA; Pitt, TL; Primavesi, RJ; Speller, DC | 1 |
Angehrn, P | 1 |
Miranda, DR; Stoutenbeek, CP; Van Saene, HK; Zandstra, DF | 1 |
Cobbs, CG; Elliott, AM; Karam, GH | 1 |
Pohlod, DJ; Saravolatz, LD | 1 |
Brandis, M; Burghard, R; Gordjani, N; Leititis, JU; Mathäi, H; Mergehenn, G; Müller, D | 1 |
Fernández-del Castillo, C; Ferraro, MJ; Foitzik, T; Mithöfer, K; Rattner, DW; Warshaw, AL | 1 |
Hammond, JM; Potgieter, PD | 2 |
Carson, M; Hellyar, A | 1 |
Eckel, HE; Lippert, KL; Merz, E; Schmitt, HJ; Schönberger, W; Zorowka, P | 1 |
Bion, JF; Crosby, HA; Elliott, TS; Penn, CW | 1 |
Enríquez, A; González-Lahoz, J; Guinea, J; Valencia, ME | 1 |
Alestig, K; Eilard, T; Ek, E; Hebelka, M; Johansson, E; Olinder-Nielsen, AM; Sandberg, T | 1 |
Exner, H; Finke, U; Joosten, U; Schardey, HM; Schauer, R; Schildberg, FW; Staubach, KH | 1 |
Caron, F | 1 |
Hubbard, RW; Slocum, R | 1 |
Rommes, JH; van Saene, HK; Zandstra, DF | 1 |
Geraedts, AA; Tytgat, GN; van der Ende, A; van der Hulst, RW; van der Voort, PH; Zandstra, DF | 1 |
Laynez, P; Martínez, A; Miguélez, M; Romero, R | 1 |
Bethe, U; Cornely, OA; Diehl, V; Fätkenheuer, G; Franzen, C; Hartmann, P; Salzberger, B; Schrappe, M; Seifert, H; Steinmetz, T | 1 |
van den Anker, JN | 1 |
Aquino, VM; Scothorn, DJ; Timmons, CF; Winick, NJ | 1 |
de la Cal, MA; Kolak, J; Peric, M; Silvestre, L; van Saene, HK | 1 |
Doi, M; Hayashi, M; Murakami, T; Nakashima, K; Nakayasu, H; Sawada, H | 1 |
Aschoff, R; Baldauf, A; Leike, S; Meurer, M; Wirth, MP | 1 |
Armero, C; Gobernado, M; González, F; López-Quílez, A; Perpiñán, H; Sahuquillo-Arce, JM; Selva, M; Vanaclocha, H | 1 |
Bonten, MJ; de Smet, AM; Kluytmans, JA; Melsen, WG | 1 |
Franz, C; Gerber, A; Mainz, JG | 1 |
Bonten, MJ; de Smet, AM; Oostdijk, EA | 1 |
Bovyn, T; Dobbelaere, A; Ide, L; Jeannin, P | 1 |
Kostrzewa, M; Schubert, S; Sparbier, K | 1 |
Ait Hamou, N; Amour, J; Bouglé, A; Dujardin, O; El-Helali, N; Lebreton, G; Lepère, V; Petijean, G; Salem, JE; Vidal, C | 1 |
Barsuk, AL; Lovtsova, LV; Nekaeva, ES; Urakov, AL | 1 |
Caljon, B; Crombé, F; De Geyter, D; Demuyser, T; Janssen, T; Muyldermans, A; Piérard, D; Seyler, L; Vanstokstraeten, R; Wybo, I | 1 |
5 review(s) available for tobramycin and cefotaxime
Article | Year |
---|---|
Respiratory infections: clinical evaluation.
Topics: Amikacin; Carbenicillin; Cefotaxime; Cystic Fibrosis; Drug Therapy, Combination; Enterobacteriaceae; Haemophilus influenzae; Humans; Piperacillin; Pseudomonas Infections; Respiratory Tract Infections; Streptococcus; Streptococcus pneumoniae; Tobramycin | 1985 |
[Current role of aminoglycosides in the treatment of acute pyelonephritis].
Topics: Acute Disease; Administration, Oral; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Cefadroxil; Cefotaxime; Cephalosporins; Ciprofloxacin; Clinical Trials as Topic; Drug Therapy, Combination; Female; Gentamicins; Humans; Infusions, Intravenous; Inpatients; Male; Norfloxacin; Pyelonephritis; Recurrence; Time Factors; Tobramycin; Urinary Tract Infections | 1998 |
[Selective decontamination of the digestive tract reduces mortality in intensive care patients].
Topics: Amphotericin B; Bacterial Infections; Cefotaxime; Clinical Protocols; Colistin; Critical Care; Critical Illness; Cross Infection; Decontamination; Digestive System; Drug Therapy, Combination; Female; Humans; Intensive Care Units; Male; Survival Rate; Tobramycin | 1999 |
Control of bacterial pneumonia during mechanical ventilation.
Topics: Amphotericin B; Anti-Bacterial Agents; Cefotaxime; Chemoprevention; Cross Infection; Equipment Contamination; Humans; Hygiene; Intensive Care Units; Length of Stay; Pneumonia, Bacterial; Polymyxin B; Respiration, Artificial; Tobramycin | 2005 |
Selective Intestinal Decontamination as a Method for Preventing Infectious Complications (Review).
Topics: Anti-Bacterial Agents; Cefotaxime; Decontamination; Drug Resistance, Microbial; Humans; Tobramycin | 2021 |
25 trial(s) available for tobramycin and cefotaxime
Article | Year |
---|---|
Selective decontamination of the digestive tract: a stratified, randomized, prospective study in a mixed intensive care unit.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Bacterial Infections; Cefotaxime; Cost-Benefit Analysis; Critical Care; Cross Infection; Digestive System; Drug Therapy, Combination; Female; Humans; Length of Stay; Male; Middle Aged; Polymyxins; Prospective Studies; Tobramycin | 1991 |
Empiric treatment of serious infections in patients with cancer: randomised comparison of two combinations.
Topics: Administration, Oral; Cefotaxime; Drug Synergism; Drug Therapy, Combination; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Infusions, Intravenous; Neoplasms; Neutropenia; Ofloxacin; Tobramycin | 1991 |
[Pneumonia prevention in long-term mechanically ventilated patients: selective skin decontamination according to Stoutenbeek or prevention of colonization according to Unertl? A prospective randomized comparison of both treatments].
Topics: Adult; Aged; Aged, 80 and over; Amphotericin B; Anti-Bacterial Agents; Bacterial Infections; Cefotaxime; Colistin; Critical Care; Female; Gentamicins; Humans; Male; Middle Aged; Pneumonia; Polymyxin B; Prospective Studies; Respiration, Artificial; Time Factors; Tobramycin | 1991 |
A multiple-center comparative study of the kidney tolerance of ceftazidime versus cefotaxime and tobramycin.
Topics: Aminopeptidases; Biomarkers; CD13 Antigens; Cefotaxime; Ceftazidime; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Kidney; Multicenter Studies as Topic; Tobramycin | 1987 |
[Randomized prospective study of ceftazidime versus a cefotaxime-tobramycin combination in acute leukemia in therapeutic aplasia].
Topics: Adolescent; Adult; Cefotaxime; Ceftazidime; Drug Therapy, Combination; Female; Humans; Infection Control; Leukemia; Male; Prospective Studies; Random Allocation; Remission Induction; Tobramycin | 1988 |
Cefotaxime vs nafcillin and tobramycin for the treatment of serious infection. Comparative cost-effectiveness.
Topics: Bacterial Infections; Cefotaxime; Clinical Trials as Topic; Cost-Benefit Analysis; Double-Blind Method; Fees and Charges; Humans; Kidney; Maryland; Nafcillin; Random Allocation; Regression Analysis; Time Factors; Tobramycin | 1986 |
Prevention of colonization and infection in critically ill patients: a prospective randomized study.
Topics: Adult; Aged; Aged, 80 and over; Amphotericin B; Anti-Bacterial Agents; Bacteria; Cefotaxime; Child; Colistin; Cross Infection; Digestive System; Drug Therapy, Combination; Enterobacteriaceae Infections; Female; Humans; Male; Middle Aged; Oropharynx; Prospective Studies; Pseudomonas Infections; Random Allocation; Respiratory System; Tobramycin | 1988 |
[Comparison of the efficacy of cefotaxime alone and the combination cefazolin-tobramycin in the treatment of enterobacterial septicemia].
Topics: Aged; Cefazolin; Cefotaxime; Drug Therapy, Combination; Enterobacteriaceae Infections; Humans; Middle Aged; Prospective Studies; Random Allocation; Sepsis; Tobramycin | 1987 |
Studies of risk factors for aminoglycoside nephrotoxicity.
Topics: Acute Kidney Injury; Age Factors; Aminoglycosides; Cefotaxime; Clinical Trials as Topic; Double-Blind Method; Humans; Kidney Diseases; Nafcillin; Probability; Risk; Time Factors; Tobramycin | 1986 |
[Clinical evaluation of ceftazidime and the combined administration of cefotaxime and tobramycin in the treatment of urinary tract infections. Prospective and randomized studies].
Topics: Adult; Cefotaxime; Ceftazidime; Clinical Trials as Topic; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Prospective Studies; Random Allocation; Tobramycin; Urinary Tract Infections | 1986 |
Increased risk of renal dysfunction due to interaction of liver disease and aminoglycosides.
Topics: Aminoglycosides; Anti-Bacterial Agents; Cefotaxime; Double-Blind Method; Female; Humans; Kidney Diseases; Liver Diseases; Male; Middle Aged; Nafcillin; Tobramycin | 1986 |
Cefotaxime compared with nafcillin plus tobramycin for serious bacterial infections. A randomized, double-blind trial.
Topics: Adult; Aged; Bacterial Infections; Cefotaxime; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Enterobacter; Enterobacteriaceae Infections; Escherichia coli Infections; Female; Humans; Infusions, Parenteral; Kidney Diseases; Male; Middle Aged; Nafcillin; Penicillin Resistance; Prognosis; Pseudomonas Infections; Random Allocation; Tobramycin; Urinary Tract Infections | 1984 |
Short-term antibiotherapy for peritonitis: prospective, randomized trial comparing cefotaxime-metronidazole and clindamycin-tobramycin.
Topics: Cefotaxime; Clindamycin; Clinical Trials as Topic; Diverticulitis; Drug Combinations; Humans; Metronidazole; Peritonitis; Prospective Studies; Random Allocation; Tobramycin | 1984 |
Tobramycin nephrotoxicity: failure of cefotaxime to potentiate renal toxicity.
Topics: Adolescent; Adult; Aged; Aminopeptidases; Anti-Bacterial Agents; CD13 Antigens; Cefotaxime; Creatinine; Drug Therapy, Combination; Female; Humans; Kidney; Male; Middle Aged; Tobramycin | 1982 |
A preliminary report on the use of ceftizoxime vs. clindamycin/tobramycin for the therapy of intra-abdominal and pelvic infections.
Topics: Abdomen; Anti-Bacterial Agents; Bacterial Infections; Cefotaxime; Ceftizoxime; Clindamycin; Drug Therapy, Combination; Humans; Pelvis; Tobramycin | 1982 |
Ceftizoxime in the treatment of urinary tract infection in spinal cord injury patients: comparison with tobramycin.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Cefotaxime; Ceftizoxime; Female; Humans; Male; Middle Aged; Recurrence; Spinal Cord Injuries; Tobramycin; Urinary Tract Infections | 1982 |
Urinary excretion of adenosine deaminase binding protein in neonates treated with tobramycin.
Topics: Anti-Bacterial Agents; Bacterial Infections; beta 2-Microglobulin; Biomarkers; Cefotaxime; Cephalosporins; Creatinine; Dipeptidyl Peptidase 4; Humans; Infant, Newborn; Prospective Studies; Tobramycin | 1995 |
Long-term effects of selective decontamination on antimicrobial resistance.
Topics: Adult; Amphotericin B; APACHE; Bacteria; Cefotaxime; Colistin; Cross Infection; Digestive System; Double-Blind Method; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Humans; Intensive Care Units; Male; Prospective Studies; Respiration, Artificial; Tobramycin | 1995 |
Is there a role for selective decontamination of the digestive tract in primarily infected patients in the ICU?
Topics: Administration, Oral; Adult; Amphotericin B; Cefotaxime; Colistin; Critical Care; Critical Illness; Cross Infection; Digestive System; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Intensive Care Units; Length of Stay; Male; Middle Aged; Placebos; Prospective Studies; Respiration, Artificial; Survival Rate; Tobramycin | 1995 |
Serial measurements of transient evoked otoacoustic emissions (TEOAEs) in healthy newborns and in newborns with perinatal infection.
Topics: Ampicillin; Anti-Bacterial Agents; Auditory Perception; Bacterial Infections; Cefotaxime; Cochlea; Evoked Potentials, Auditory; Female; Follow-Up Studies; Humans; Infant, Newborn; Male; Netilmicin; Reflex, Acoustic; Reproducibility of Results; Tobramycin | 1993 |
Aminoglycosides do not improve the efficacy of cephalosporins for treatment of acute pyelonephritis in women.
Topics: Adult; Aged; Anti-Bacterial Agents; Cefotaxime; Cephalosporins; Drug Therapy, Combination; Female; Humans; Middle Aged; Prospective Studies; Pyelonephritis; Tobramycin | 1997 |
[Cost savings by disinfection for prevention of surgical wound dehiscence after gastrectomy].
Topics: Aged; Amphotericin B; Antibiotic Prophylaxis; Cefotaxime; Cost Savings; Double-Blind Method; Drug Therapy, Combination; Female; Gastrectomy; Humans; Male; Middle Aged; Polymyxin B; Prospective Studies; Stomach Neoplasms; Surgical Wound Dehiscence; Surgical Wound Infection; Survival Rate; Tobramycin; Vancomycin | 1997 |
Randomized controlled monocentric comparison of once daily ceftriaxone with tobramycin and cefotaxime three times daily with tobramycin in neutropenic fever.
Topics: Adult; Aged; Cefotaxime; Ceftriaxone; Drug Therapy, Combination; Female; Fever; Humans; Male; Middle Aged; Neutropenia; Time Factors; Tobramycin | 2001 |
Selective decontamination of the oral and digestive tract in surgical versus non-surgical patients in intensive care in a cluster-randomized trial.
Topics: Administration, Oral; Amphotericin B; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacteremia; Cefotaxime; Cluster Analysis; Colistin; Critical Care; Cross Infection; Decontamination; Digestive System Diseases; Drug Combinations; Female; Hospital Mortality; Humans; Infusions, Intravenous; Intubation, Gastrointestinal; Length of Stay; Male; Middle Aged; Oropharynx; Pharyngeal Diseases; Respiration, Artificial; Tobramycin | 2012 |
Effects of decontamination of the digestive tract and oropharynx in intensive care unit patients on 1-year survival.
Topics: Administration, Intravenous; Aged; Amphotericin B; Anti-Bacterial Agents; Cefotaxime; Cluster Analysis; Colistin; Critical Care; Cross Infection; Cross-Over Studies; Decontamination; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Gastrointestinal Tract; Hospital Mortality; Humans; Intensive Care Units; Intubation, Gastrointestinal; Male; Middle Aged; Netherlands; Odds Ratio; Oropharynx; Primary Prevention; Survival Analysis; Tobramycin; Treatment Outcome | 2013 |
99 other study(ies) available for tobramycin and cefotaxime
Article | Year |
---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
First identification of Pseudomonas aeruginosa isolates producing a KPC-type carbapenem-hydrolyzing beta-lactamase.
Topics: beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Hydrolysis; Microbial Sensitivity Tests; Pseudomonas aeruginosa | 2007 |
Spread of extended-spectrum beta-lactamase CTX-M-producing escherichia coli clinical isolates in community and nosocomial environments in Portugal.
Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; Community-Acquired Infections; Cross Infection; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Microbial Sensitivity Tests; Middle Aged; Portugal | 2007 |
Spread in an Italian hospital of a clonal Acinetobacter baumannii strain producing the TEM-92 extended-spectrum beta-lactamase.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Cross Infection; Humans; Italy; Microbial Sensitivity Tests | 2007 |
Enterobacteriaceae bloodstream infections: presence of integrons, risk factors, and outcome.
Topics: Bacteremia; Community-Acquired Infections; Cross Infection; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enterobacteriaceae Infections; Gene Transfer, Horizontal; Humans; Infectious Disease Transmission, Professional-to-Patient; Integrons; Microbial Sensitivity Tests; Nucleic Acid Amplification Techniques; Polymerase Chain Reaction; Prospective Studies; Risk Factors; Sequence Analysis, DNA; Treatment Outcome | 2007 |
Transferable resistance to aminoglycosides by methylation of G1405 in 16S rRNA and to hydrophilic fluoroquinolones by QepA-mediated efflux in Escherichia coli.
Topics: Amino Acid Motifs; Amino Acid Sequence; Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; Conjugation, Genetic; Conserved Sequence; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Escherichia coli; Escherichia coli Proteins; Fluoroquinolones; Genes, rRNA; Methylation; Methyltransferases; Microbial Sensitivity Tests; Molecular Sequence Data; Norfloxacin; Plasmids; Sequence Analysis, DNA; Sequence Homology, Amino Acid | 2007 |
Cloning, nucleotide sequencing, and analysis of the AcrAB-TolC efflux pump of Enterobacter cloacae and determination of its involvement in antibiotic resistance in a clinical isolate.
Topics: Bacterial Proteins; Base Sequence; beta-Lactamases; Carrier Proteins; Cloning, Molecular; DNA, Bacterial; Drug Resistance, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Genes, MDR; Genetic Vectors; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Porins | 2007 |
Prevalence and expression of the plasmid-mediated quinolone resistance determinant qnrA1.
Topics: Anti-Infective Agents; Base Sequence; Ciprofloxacin; DNA, Bacterial; Drug Resistance, Bacterial; Enterobacter cloacae; Enterobacteriaceae; Gene Expression Regulation, Bacterial; Genes, Bacterial; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Polymerase Chain Reaction; Promoter Regions, Genetic; Quinolones; Reverse Transcriptase Polymerase Chain Reaction; Sequence Analysis, DNA; Sequence Homology, Nucleic Acid | 2007 |
Escherichia coli isolate coproducing 16S rRNA Methylase and CTX-M-type extended-spectrum beta-lactamase isolated from an outpatient in the United States.
Topics: Ambulatory Care; Aminoglycosides; Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Female; Humans; Methyltransferases; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; RNA, Ribosomal, 16S; Sequence Analysis, DNA; United States | 2008 |
Synergy between polyethylenimine and different families of antibiotics against a resistant clinical isolate of Pseudomonas aeruginosa.
Topics: Aminoglycosides; Anti-Bacterial Agents; Carbenicillin; Ceftazidime; Ciprofloxacin; Drug Resistance, Bacterial; Drug Synergism; Humans; Microbial Sensitivity Tests; Novobiocin; Ofloxacin; Piperacillin; Polyethyleneimine; Pseudomonas aeruginosa; Pseudomonas Infections; Rifampin; Ticarcillin; Tobramycin | 2008 |
Plasmid-mediated qepA gene among Escherichia coli clinical isolates from Japan.
Topics: Anti-Bacterial Agents; Conjugation, Genetic; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Fluoroquinolones; Hospitals; Humans; Japan; Microbial Sensitivity Tests; Plasmids; Prevalence | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
bla(IMP-4) in different genetic contexts in Enterobacteriaceae isolates from Australia.
Topics: Australia; Bacterial Proteins; beta-Lactamases; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Molecular Sequence Data; Polymerase Chain Reaction; Sequence Analysis, DNA | 2008 |
Spread of OXA-48-positive carbapenem-resistant Klebsiella pneumoniae isolates in Istanbul, Turkey.
Topics: Bacterial Proteins; beta-Lactamases; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Models, Genetic; Turkey | 2008 |
VIM-15 and VIM-16, two new VIM-2-like metallo-beta-lactamases in Pseudomonas aeruginosa isolates from Bulgaria and Germany.
Topics: Amino Acid Substitution; Bacterial Proteins; beta-Lactamases; Bulgaria; Catalysis; Germany; Hydrolysis; Isoenzymes; Kinetics; Microbial Sensitivity Tests; Molecular Sequence Data; Pseudomonas aeruginosa; Sequence Analysis, DNA | 2008 |
Characterization of the new metallo-beta-lactamase VIM-13 and its integron-borne gene from a Pseudomonas aeruginosa clinical isolate in Spain.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; beta-Lactam Resistance; beta-Lactamases; Cloning, Molecular; DNA Primers; DNA, Bacterial; Genes, Bacterial; Genetic Variation; Humans; Imipenem; Integrons; Kinetics; Meropenem; Molecular Sequence Data; Phylogeny; Pseudomonas aeruginosa; Pseudomonas Infections; Recombinant Proteins; Sequence Homology, Amino Acid; Spain; Thienamycins | 2008 |
Plasmid-mediated quinolone resistance pump QepA2 in an Escherichia coli isolate from France.
Topics: Aged; Base Sequence; DNA Primers; DNA, Bacterial; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Female; Fluoroquinolones; France; Genes, Bacterial; Humans; Models, Genetic; Molecular Sequence Data; Plasmids | 2008 |
Plasmid-mediated 16S rRNA methylases among extended-spectrum beta-lactamase-producing Enterobacteriaceae isolates.
Topics: Anti-Bacterial Agents; beta-Lactamases; Conjugation, Genetic; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Escherichia coli; Humans; Methyltransferases; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Sequence Analysis, DNA; Transformation, Bacterial | 2008 |
Nationwide survey of CTX-M-type extended-spectrum beta-lactamases among Klebsiella pneumoniae isolates in Slovenian hospitals.
Topics: Anti-Bacterial Agents; beta-Lactamases; Electrophoresis, Gel, Pulsed-Field; Genes, Bacterial; Hospitals; Klebsiella pneumoniae; Microbial Sensitivity Tests; Slovenia | 2009 |
Detection of the pandemic O25-ST131 human virulent Escherichia coli CTX-M-15-producing clone harboring the qnrB2 and aac(6')-Ib-cr genes in a dog.
Topics: Animals; Anti-Bacterial Agents; Dogs; Drug Resistance, Bacterial; Escherichia coli; Genes, Bacterial; Humans; Plasmids; Virulence | 2009 |
Characterization and sequence analysis of extended-spectrum-{beta}-lactamase-encoding genes from Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis isolates collected during tigecycline phase 3 clinical trials.
Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactamases; Clinical Trials, Phase III as Topic; DNA Primers; Drug Resistance, Bacterial; Escherichia coli; Humans; Isoelectric Focusing; Klebsiella pneumoniae; Microbial Sensitivity Tests; Minocycline; Proteus mirabilis; Reverse Transcriptase Polymerase Chain Reaction; Tigecycline | 2009 |
Carbapenem resistance among Pseudomonas aeruginosa strains from India: evidence for nationwide endemicity of multiple metallo-beta-lactamase clones (VIM-2, -5, -6, and -11 and the newly characterized VIM-18).
Topics: Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Humans; India; Microbial Sensitivity Tests; Molecular Sequence Data; Prevalence; Pseudomonas aeruginosa; Ribotyping | 2009 |
First organisms with acquired metallo-beta-lactamases (IMP-13, IMP-22, and VIM-2) reported in Austria.
Topics: Austria; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Pseudomonas aeruginosa; Pseudomonas Infections; Sequence Analysis, DNA | 2009 |
Further identification of CTX-M-2 extended-spectrum beta-lactamase in Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Brazil; Ceftriaxone; Clindamycin; Drug Resistance, Multiple, Bacterial; Fatal Outcome; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections | 2009 |
Prevalence of aac(6')-Ib-cr encoding a ciprofloxacin-modifying enzyme among Enterobacteriaceae blood isolates in Korea.
Topics: Acetyltransferases; beta-Lactamases; Ciprofloxacin; Conjugation, Genetic; Enterobacteriaceae; Microbial Sensitivity Tests; Plasmids | 2009 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Complete nucleotide sequences of plasmids pEK204, pEK499, and pEK516, encoding CTX-M enzymes in three major Escherichia coli lineages from the United Kingdom, all belonging to the international O25:H4-ST131 clone.
Topics: beta-Lactamases; Computational Biology; Escherichia coli; Models, Genetic; Molecular Sequence Data; Open Reading Frames; Plasmids; United Kingdom | 2009 |
Klebsiella pneumoniae AcrAB efflux pump contributes to antimicrobial resistance and virulence.
Topics: Animals; Anti-Bacterial Agents; Bronchoalveolar Lavage Fluid; Culture Media; Defensins; DNA, Bacterial; Drug Resistance, Bacterial; Genotype; Humans; Klebsiella Infections; Klebsiella pneumoniae; Lipopolysaccharides; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Phenotype; Plasmids; Polymyxin B; Polysaccharides; Repressor Proteins; RNA, Bacterial | 2010 |
Screening and quantification of the expression of antibiotic resistance genes in Acinetobacter baumannii with a microarray.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; DNA, Bacterial; DNA, Complementary; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Genes, MDR; Metals, Heavy; Microbial Sensitivity Tests; Mutation; Oligonucleotide Array Sequence Analysis; Reproducibility of Results; Reverse Transcriptase Polymerase Chain Reaction; RNA, Bacterial | 2010 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Acinetobacter baumannii increases tolerance to antibiotics in response to monovalent cations.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Bacterial Proteins; Cations, Monovalent; Culture Media; Drug Resistance, Bacterial; Gene Expression Profiling; Gene Expression Regulation, Bacterial; Humans; Microbial Sensitivity Tests; Oligonucleotide Array Sequence Analysis; Proteomics; Sodium Chloride; Virulence Factors | 2010 |
Efflux pumps, OprD porin, AmpC beta-lactamase, and multiresistance in Pseudomonas aeruginosa isolates from cystic fibrosis patients.
Topics: Bacterial Outer Membrane Proteins; Bacterial Proteins; beta-Lactamases; Cystic Fibrosis; Drug Resistance, Bacterial; Drug Resistance, Multiple; Electrophoresis, Gel, Pulsed-Field; Humans; Membrane Transport Proteins; Mutation; Porins; Pseudomonas aeruginosa; Pseudomonas Infections; Reverse Transcriptase Polymerase Chain Reaction; Up-Regulation | 2010 |
In vivo selection of a missense mutation in adeR and conversion of the novel blaOXA-164 gene into blaOXA-58 in carbapenem-resistant Acinetobacter baumannii isolates from a hospitalized patient.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Bacterial Proteins; Carbapenems; Drug Resistance, Bacterial; Fatal Outcome; Humans; Male; Middle Aged; Molecular Sequence Data; Mutation, Missense; Reverse Transcriptase Polymerase Chain Reaction | 2010 |
Synthesis and antimicrobial profile of N-substituted imidazolium oximes and their monoquaternary salts against multidrug resistant bacteria.
Topics: Anti-Infective Agents; Bacterial Infections; Drug Resistance, Multiple; Fungi; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Imidazoles; Microbial Sensitivity Tests; Mycoses; Oximes | 2013 |
[Experiences with triple antibiotic combination in neonatal infection].
Topics: Azlocillin; Bacteriological Techniques; Cefotaxime; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Infant, Newborn; Infant, Premature, Diseases; Male; Microbial Sensitivity Tests; Risk Factors; Sepsis; Staphylococcal Infections; Streptococcal Infections; Streptococcus agalactiae; Tobramycin | 1992 |
Beta-lactam enhancement of aminoglycoside activity under conditions of reduced pH and oxygen tension that may exist in infected tissues.
Topics: Abscess; Aerobiosis; Amikacin; Anaerobiosis; Animals; Anti-Bacterial Agents; Bacteroides fragilis; Cefotaxime; Drug Synergism; Enterobacteriaceae; Escherichia coli; Humans; Hydrogen-Ion Concentration; Mice; Oxygen; Pseudomonas aeruginosa; Ticarcillin; Tobramycin | 1992 |
Evaluation of intraosseous vs intravenous antibiotic levels in a porcine model.
Topics: Animals; Anti-Bacterial Agents; Bone Marrow; Cefotaxime; Chloramphenicol; Female; Infusions, Intravenous; Infusions, Parenteral; Male; Models, Biological; Prospective Studies; Swine; Tobramycin; Vancomycin | 1991 |
Effect of ceftazidime, cefotaxime, and cefoperazone on serum tobramycin concentrations.
Topics: Cefoperazone; Cefotaxime; Ceftazidime; Drug Interactions; Humans; Tobramycin | 1991 |
Imipenem-antibiotic monotherapy in juvenile cancer patients with neutropenia.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Cefotaxime; Child; Child, Preschool; Cilastatin; Drug Therapy, Combination; Female; Humans; Imipenem; Infant; Male; Neoplasms; Neutropenia; Piperacillin; Retrospective Studies; Sepsis; Ticarcillin; Tobramycin | 1990 |
[Dosage adjustment of drugs during continuous hemofiltration. Results and practical consequences of a prospective clinical study].
Topics: Adult; Aged; Cefotaxime; Ceftazidime; Digitoxin; Digoxin; Hemofiltration; Humans; Imipenem; Kidney Failure, Chronic; Metronidazole; Middle Aged; Netilmicin; Pharmaceutical Preparations; Phenobarbital; Phenytoin; Theophylline; Tobramycin; Vancomycin | 1989 |
Role of parenteral antibiotherapy in gastrointestinal tract flora suppression. A study in children treated with high-dose chemotherapy and autologous bone marrow transplantation.
Topics: Adolescent; Agranulocytosis; Bone Marrow Transplantation; Cefotaxime; Child; Child, Preschool; Digestive System; Dose-Response Relationship, Drug; Drug Combinations; Feces; Female; Gentamicins; Gram-Positive Bacteria; Humans; Infusions, Parenteral; Male; Mezlocillin; Moxalactam; Sulfamethizole; Suppression, Genetic; Tobramycin; Transplantation, Autologous; Trimethoprim | 1989 |
[Enterobacter cloacae infection and marked hypophosphatemia in a patient on hemodialysis].
Topics: Administration, Oral; Cefotaxime; Enterobacter; Enterobacteriaceae Infections; Humans; Male; Middle Aged; Phosphates; Renal Dialysis; Tobramycin | 1989 |
[Frequency of colonization and pneumonia and development of resistance in long-term ventilated intensive-care patients subjected to selective decontamination of the digestive tract].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Anti-Bacterial Agents; Bacteria; Cefotaxime; Colistin; Critical Care; Digestive System; Female; Humans; Male; Middle Aged; Oropharynx; Pneumonia; Respiration, Artificial; Time Factors; Tobramycin | 1989 |
Investigation of the immune status of mice during and following selective decontamination of the digestive tract.
Topics: Amphotericin B; Animals; Antibody Formation; Bacitracin; Cefotaxime; Colistin; Digestive System; Drug Therapy, Combination; Female; Gram-Negative Bacteria; Hypersensitivity, Delayed; Immunity, Cellular; Lymphocyte Activation; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Random Allocation; Streptomycin; Tobramycin | 1989 |
Urinary alanine-aminopeptidase (AAP) excretion in patients with urinary tract infection treated with ceftazidime (CAZ) or cefotaxime (CTX) plus tobramycin (TOB).
Topics: Adult; Aminopeptidases; CD13 Antigens; Cefotaxime; Ceftazidime; Clinical Enzyme Tests; Creatinine; Drug Therapy, Combination; Escherichia coli Infections; Female; Humans; Kidney Function Tests; Male; Tobramycin; Urinary Tract Infections | 1988 |
Comparative in vitro activity of lomefloxacin and other antimicrobials against 597 microorganisms causing bacteremia.
Topics: Anti-Bacterial Agents; Bacteria; Cefotaxime; Ceftazidime; Enoxacin; Fluoroquinolones; Humans; Imipenem; Microbial Sensitivity Tests; Norfloxacin; Quinolones; Sepsis; Tobramycin | 1988 |
Comparative study of serum bactericidal activity of cefotaxime alone or in combination with tobramycin.
Topics: Adult; Cefotaxime; Chromatography, High Pressure Liquid; Drug Interactions; Enterobacter; Enterobacteriaceae; Female; Humans; Kinetics; Klebsiella; Listeria monocytogenes; Male; Pseudomonas; Serratia marcescens; Tobramycin | 1986 |
Comparative evaluation of the diffusion of tobramycin and cefotaxime out of antibiotic-impregnated polymethylmethacrylate beads.
Topics: Anti-Bacterial Agents; Cefotaxime; Diffusion; Escherichia coli; Klebsiella; Methylmethacrylates; Microbial Sensitivity Tests; Osteomyelitis; Postoperative Complications; Time Factors; Tobramycin | 1988 |
Efficacy of a combination of cefotaxime, tobramycin and vancomycin as antibiotic therapy for neutropenia.
Topics: Agranulocytosis; Anti-Bacterial Agents; Bacterial Infections; Cefotaxime; Drug Therapy, Combination; Humans; Neutropenia; Tobramycin; Vancomycin | 1988 |
Cefotaxime combined with selective decontamination in long term intensive care unit patients. Virtual absence of emergence of resistance.
Topics: Administration, Oral; Bacterial Infections; Cefotaxime; Colistin; Critical Care; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Gram-Negative Bacteria; Humans; Infusions, Intravenous; Male; Time Factors; Tobramycin | 1988 |
Antimicrobial activity of cefotiam combinations against Enterobacteriaceae moderately susceptible or resistant to this new cephalosporin.
Topics: Amikacin; Cefotaxime; Cefotiam; Drug Combinations; Drug Resistance, Microbial; Drug Synergism; Enterobacteriaceae; Gentamicins; Microbial Sensitivity Tests; Netilmicin; Tobramycin | 1986 |
Optimal conditions for injection of tobramycin and cefmenoxime into burn patients.
Topics: Adult; Aged; Bacterial Infections; Burns; Cefmenoxime; Cefotaxime; Female; Humans; Infusions, Parenteral; Injections, Intramuscular; Injections, Intravenous; Male; Middle Aged; Tobramycin | 1987 |
The in-vitro activity and beta-lactamase stability of carumonam.
Topics: Anti-Bacterial Agents; Aztreonam; beta-Lactamase Inhibitors; beta-Lactamases; Cefotaxime; Ceftazidime; Culture Media; Gram-Negative Aerobic Bacteria; Microbial Sensitivity Tests; Piperacillin; Tobramycin | 1986 |
In vitro activity against aerobic and anaerobic gram-positive and gram-negative bacteria and beta-lactamase stability of RS-533, a novel carbapenem.
Topics: Aztreonam; beta-Lactamase Inhibitors; beta-Lactamases; Cefoperazone; Cefotaxime; Cefoxitin; Ceftazidime; Gram-Negative Bacteria; Gram-Positive Bacteria; Imipenem; Microbial Sensitivity Tests; Piperacillin; Thienamycins; Tobramycin | 1986 |
[Granulocyte function modified by antibiotics].
Topics: Anti-Bacterial Agents; Cefotaxime; Dose-Response Relationship, Drug; Doxycycline; Granulocytes; Humans; Luminescent Measurements; Neutrophils; Phagocytosis; Thienamycins; Tobramycin | 1986 |
Recent advances in the control of infection in patients with thoracic injury.
Topics: Adolescent; Adult; Aged; Amphotericin B; Bacterial Infections; Cefotaxime; Child; Child, Preschool; Drug Therapy, Combination; Enterobacteriaceae Infections; Humans; Infant; Middle Aged; Thoracic Injuries; Tobramycin | 1986 |
[In vitro study of the synergistic effect of cefotiam- aminoglycoside combinations on strains of low susceptibility to this cephalosporin].
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Cefotaxime; Cefotiam; Drug Resistance, Microbial; Drug Synergism; Enterobacteriaceae; Gentamicins; Microbial Sensitivity Tests; Netilmicin; Tobramycin | 1985 |
Cefotaxime and nafcillin-tobramycin.
Topics: Bacterial Infections; Cefotaxime; Drug Therapy, Combination; Humans; Nafcillin; Tobramycin | 1985 |
[Endolymphatic therapy in the combined treatment of patients with respiratory diseases].
Topics: Adolescent; Adult; Aged; Ampicillin; Anti-Bacterial Agents; Bronchitis; Cefotaxime; Cefuroxime; Evaluation Studies as Topic; Female; Humans; Injections, Intralymphatic; Lung Abscess; Male; Middle Aged; Pneumonia; Respiratory Tract Diseases; Tobramycin | 1985 |
New cephalosporins: in-vitro activity against gram-negative bacilli and suggestions for possible clinical use.
Topics: Cefotaxime; Ceftazidime; Cephalosporins; Gram-Negative Bacteria; Humans; Moxalactam; Tobramycin | 1984 |
Ceftriaxone for meningitis, due to Escherichia coli, which developed during tobramycin therapy.
Topics: Cefotaxime; Ceftriaxone; Drug Resistance, Microbial; Escherichia coli Infections; Female; Humans; Meningitis; Middle Aged; Tobramycin | 1984 |
Combination effect of cefmenoxime with four aminoglycosides on Enterobacteriaceae susceptible and moderately susceptible to this new cephalosporin.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Cefmenoxime; Cefotaxime; Drug Resistance, Microbial; Drug Synergism; Enterobacteriaceae; Enterobacteriaceae Infections; Gentamicins; Humans; Netilmicin; Species Specificity; Tobramycin | 1984 |
Activities of two aminoglycosides and five newer beta-lactam antibiotics: safer alternatives to aminoglycosides?
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; Cefotaxime; Ceftazidime; Humans; Microbial Sensitivity Tests; Moxalactam; Netilmicin; Piperacillin; Tobramycin | 1984 |
Sensitivity testing and synergy.
Topics: Azlocillin; Bacteria; Cefotaxime; Cephalosporins; Culture Media; Drug Synergism; Microbial Sensitivity Tests; Penicillins; Tobramycin | 1980 |
[Kinetics of bactericidial function of cefotaxim against Pseudomonas aeruginosa alone and in combination with tobramycin].
Topics: Anti-Bacterial Agents; Cefotaxime; Cephalosporins; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; In Vitro Techniques; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Tobramycin | 1980 |
Activity of cefotaxime-aminoglycoside combinations against aminoglycoside-resistant Pseudomonas.
Topics: Amikacin; Anti-Bacterial Agents; Cefotaxime; Cephalosporins; Drug Resistance, Microbial; Drug Synergism; Gentamicins; Humans; Kanamycin; Pseudomonas aeruginosa; Tobramycin | 1980 |
Synergy between cefotaxime, cefsulodin, azlocillin, mezlocillin and aminoglycosides against carbenicillin resistant or sensitive Pseudomonas aeruginosa.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Azlocillin; Carbenicillin; Cefotaxime; Cefsulodin; Cephalosporins; Dibekacin; Drug Synergism; Gentamicins; Mezlocillin; Penicillin Resistance; Penicillins; Pseudomonas aeruginosa; Sisomicin; Tobramycin | 1980 |
In-vitro efficacy of cefotiam in combination with four aminoglycosides on staphylococci and Gram-negative bacteria.
Topics: Amikacin; Aminoglycosides; Cefotaxime; Cefotiam; Drug Interactions; Enterobacteriaceae; Escherichia coli; Gentamicins; Klebsiella pneumoniae; Netilmicin; Proteus; Staphylococcus; Tobramycin | 1981 |
Serum bactericidal activity of moxalactam and cefotaxime with and without tobramycin against Pseudomonas aeruginosa and Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Cefotaxime; Cephalosporins; Cephamycins; Culture Media; Humans; Injections, Intravenous; Moxalactam; Pseudomonas aeruginosa; Staphylococcus aureus; Tobramycin | 1981 |
Comparative synergistic activity of cefoperazone, cefotaxime, moxalactam, and carbenicillin, combined with tobramycin, against Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Carbenicillin; Cefoperazone; Cefotaxime; Cephalosporins; Cephamycins; Drug Synergism; Microbial Sensitivity Tests; Moxalactam; Penicillin Resistance; Pseudomonas aeruginosa; Tobramycin | 1981 |
Comparative in vitro activities of azlocillin-cefotaxime and azlocillin-tobramycin combinations against blood and multi-drug resistant bacterial isolates.
Topics: Anti-Bacterial Agents; Azlocillin; Bacteria; Cefotaxime; Drug Interactions; Humans; Microbial Sensitivity Tests; Penicillin Resistance; Penicillins; Sepsis; Tobramycin | 1982 |
The efficacy of ceftizoxime in treating infections due to organisms resistant to other antibiotics.
Topics: Bacterial Infections; Carbenicillin; Cefamandole; Cefazolin; Cefotaxime; Ceftizoxime; Cephalothin; Humans; Penicillin Resistance; Tobramycin | 1982 |
Summary of comparative clinical studies of ceftizoxime and cefamandole, cefazolin and tobramycin.
Topics: Anti-Bacterial Agents; Bacterial Infections; Cefamandole; Cefazolin; Cefotaxime; Ceftizoxime; Cephalosporins; Humans; Respiratory Tract Infections; Skin Diseases, Infectious; Tobramycin; Urinary Tract Infections | 1982 |
Synergism of ceftizoxime and tobramycin for Pseudomonas aeruginosa.
Topics: Animals; Anti-Bacterial Agents; Cefotaxime; Ceftizoxime; Drug Synergism; Drug Therapy, Combination; Humans; Mice; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin; Urinary Tract Infections | 1982 |
Protocol for the study of drug interferences in laboratory tests: cefotaxime interference in 24 clinical tests.
Topics: Blood Chemical Analysis; Cefotaxime; False Positive Reactions; Female; Gentamicins; Heart Diseases; Humans; Kidney Diseases; Liver Diseases; Male; Pregnancy; Probability; Tobramycin | 1983 |
Pseudomonas aeruginosa and Acinetobacter calcoaceticus: in vitro susceptibility of 150 clinical isolates to five beta-lactam antibiotics and tobramycin.
Topics: Acinetobacter; Anti-Bacterial Agents; Azlocillin; Carbenicillin; Cefotaxime; Ceftriaxone; Penicillin Resistance; Penicillins; Piperacillin; Pseudomonas aeruginosa; Thienamycins; Tobramycin | 1983 |
In vitro activity of ceftriaxone alone and in combination with gentamicin, tobramycin, and amikacin against Pseudomonas aeruginosa.
Topics: Amikacin; Cefotaxime; Ceftriaxone; Drug Synergism; Gentamicins; Kanamycin; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Tobramycin | 1983 |
Infection with netilmicin resistant Serratia marcescens in a special care baby unit.
Topics: Acetyltransferases; Amikacin; Cefotaxime; Cross Infection; Disease Outbreaks; Drug Resistance, Microbial; Enterobacteriaceae Infections; Gentamicins; Humans; Infant, Newborn; Netilmicin; Nurseries, Hospital; Serratia marcescens; Tobramycin | 1983 |
In vitro and in vivo synergy between ceftriaxone and aminoglycosides against Pseudomonas aeruginosa.
Topics: Amikacin; Animals; Cefotaxime; Ceftriaxone; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Gentamicins; Kanamycin; Leukopenia; Mice; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin | 1983 |
A new technique of infection prevention in the intensive care unit by selective decontamination of the digestive tract.
Topics: Anti-Bacterial Agents; Cefotaxime; Cross Infection; Digestive System; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Intensive Care Units; Polymyxins; Respiratory Tract Infections; Sepsis; Tobramycin | 1983 |
Interaction of cefotaxime and aminoglycosides against enterococci in vitro.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Cefotaxime; Drug Interactions; Enterococcus faecalis; Gentamicins; Microbial Sensitivity Tests; Streptococcus; Time Factors; Tobramycin | 1983 |
In vitro susceptibilities of 393 recent clinical isolates to WIN 49375, cefotaxime, tobramycin, and piperacillin.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Cefotaxime; Ciprofloxacin; Enterobacteriaceae; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Piperacillin; Pseudomonas; Quinolines; Staphylococcus; Tobramycin | 1984 |
Pathogenesis and prevention of early pancreatic infection in experimental acute necrotizing pancreatitis.
Topics: Acute Disease; Administration, Oral; Amphotericin B; Animals; Bacteria; Bacterial Infections; Bacterial Physiological Phenomena; Cecal Diseases; Cefotaxime; Colistin; Disease Models, Animal; Drug Therapy, Combination; Imipenem; Injections, Intravenous; Kidney Diseases; Male; Necrosis; Pancreas; Pancreatic Diseases; Pancreatitis; Rats; Rats, Sprague-Dawley; Survival Rate; Tobramycin | 1995 |
Opacification of Middlebrook agar as an aid in distinguishing Nocardia farcinica within the Nocardia asteroides complex.
Topics: Actinomycetales; Agar; Animals; Australia; Bacteriological Techniques; Cefotaxime; Culture Media; Drug Resistance, Microbial; Drug Resistance, Multiple; Erythromycin; Fish Diseases; Fishes; Humans; Nephelometry and Turbidimetry; Nocardia; Nocardia asteroides; Nocardia Infections; Species Specificity; Tobramycin | 1994 |
Antibiotic-induced release of endotoxin from bacteria in vitro.
Topics: Anti-Bacterial Agents; Cefotaxime; Ciprofloxacin; Colony Count, Microbial; Endotoxins; Enterobacter cloacae; Escherichia coli; Humans; Limulus Test; Lipopolysaccharides; Microscopy, Electron, Scanning; Piperacillin; Silver Staining; Tobramycin | 1994 |
[Infectious endocarditis caused by Escherichi coli].
Topics: Adult; Bacteremia; Cefotaxime; Cloxacillin; Drug Resistance, Microbial; Drug Therapy, Combination; Endocarditis, Bacterial; Escherichia coli; Escherichia coli Infections; Fatal Outcome; Female; HIV Infections; Humans; Injections, Intravenous; Male; Substance Abuse, Intravenous; Tobramycin; Urinary Tract Infections | 1996 |
Drug interference in amino acid analysis of urines: a graphic presentation on selected pediatric antibiotics.
Topics: Amikacin; Amino Acids; Ampicillin; Anti-Bacterial Agents; Cefotaxime; Ceftriaxone; Cephalosporins; Chromatography, Ion Exchange; Drug Contamination; Gentamicins; Humans; Infant, Newborn; Tobramycin | 1995 |
In vitro susceptibility of Helicobacter pylori to, and in vivo suppression by, antimicrobials used in selective decontamination of the digestive tract.
Topics: Administration, Topical; Amphotericin B; Anti-Bacterial Agents; Cefotaxime; Cephalosporins; Decontamination; Digestive System; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Microbial Sensitivity Tests; Polymyxins; Tobramycin | 2000 |
[Pacemaker-cable endocarditis and spondylodiscitis caused by Citrobacter koseri. Conservative treatment].
Topics: Aged; Bacteremia; Cefotaxime; Citrobacter; Discitis; Drug Therapy, Combination; Electrodes, Implanted; Endocarditis, Bacterial; Enterobacteriaceae Infections; Equipment Contamination; Humans; Imipenem; Lumbar Vertebrae; Male; Pacemaker, Artificial; Sacrum; Tobramycin | 2001 |
Molecular epidemiology of antibiotic-resistant Gram-negative bacilli in a neonatal intensive care unit during a nonoutbreak period.
Topics: Amoxicillin; Cefotaxime; Drug Resistance, Bacterial; Drug Therapy, Combination; Enterobacter; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Infections; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Infant, Newborn; Intensive Care Units, Neonatal; Length of Stay; Molecular Epidemiology; Penicillins; Risk Factors; Tobramycin | 2002 |
Rapidly fatal acute bacterial myocarditis in a nonneutropenic child with acute lymphoblastic leukemia in remission.
Topics: Acute Disease; Agammaglobulinemia; Antineoplastic Combined Chemotherapy Protocols; Cefotaxime; Child; Drug Therapy, Combination; Fatal Outcome; Female; Humans; Immunocompromised Host; Klebsiella Infections; Klebsiella pneumoniae; Myocarditis; Oxacillin; Pericarditis; Pleurisy; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction; Shoulder Pain; Tobramycin; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 2002 |
Spontaneous haemophilus influenzae type B meningoventriculitis with intraventricular debris.
Topics: Anti-Bacterial Agents; Antigens, Bacterial; Cefotaxime; Cerebrospinal Fluid; Drug Therapy, Combination; Follow-Up Studies; Haemophilus influenzae type b; Humans; Injections, Intravenous; Lateral Ventricles; Latex Fixation Tests; Magnetic Resonance Imaging; Male; Meningitis, Haemophilus; Middle Aged; Tobramycin; Tomography, X-Ray Computed | 2005 |
[Extensive Fournier gangrene. A dermatologic emergency].
Topics: Adult; Cefotaxime; Combined Modality Therapy; Drug Therapy, Combination; Emergencies; Follow-Up Studies; Fournier Gangrene; Genital Diseases, Male; Humans; Male; Metronidazole; Necrosis; Penile Diseases; Scrotum; Skin; Streptococcal Infections; Streptococcus pyogenes; Tobramycin | 2006 |
Antimicrobial resistance in more than 100,000 Escherichia coli isolates according to culture site and patient age, gender, and location.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Ampicillin; Anti-Bacterial Agents; Cefotaxime; Child; Child, Preschool; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Fosfomycin; Humans; Imipenem; Infant; Male; Middle Aged; Nitrofurantoin; Retrospective Studies; Tobramycin; Young Adult | 2011 |
Coincident diagnosis of a pulmonary abscess and ascaris lumbricoides infection: a possible causal connection?
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Antinematodal Agents; Ascariasis; Ascaris lumbricoides; Cefixime; Cefotaxime; Child; Comorbidity; Drug Therapy, Combination; Follow-Up Studies; Humans; Infusions, Intravenous; Lung Abscess; Male; Mebendazole; Tobramycin; Tomography, X-Ray Computed | 2012 |
Haemophilus influenzae: a forgotten cause of neonatal sepsis?
Topics: Anti-Bacterial Agents; Cefotaxime; Female; Haemophilus Infections; Haemophilus influenzae; Humans; Infant, Newborn; Microbial Sensitivity Tests; Sepsis; Serotyping; Time Factors; Tobramycin; Treatment Outcome | 2015 |
MBT-ASTRA: A suitable tool for fast antibiotic susceptibility testing?
Topics: Anti-Bacterial Agents; Bacteria; Cefotaxime; Ciprofloxacin; Drug Resistance, Microbial; Humans; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Tobramycin | 2016 |
PHARMECMO: Therapeutic drug monitoring and adequacy of current dosing regimens of antibiotics in patients on Extracorporeal Life Support.
Topics: Aged; Amikacin; Anti-Bacterial Agents; Cefotaxime; Cilastatin, Imipenem Drug Combination; Coronary Care Units; Drug Monitoring; Extracorporeal Membrane Oxygenation; Female; Gentamicins; Humans; Male; Middle Aged; Pilot Projects; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Sepsis; Tobramycin | 2019 |
Genotypic resistance determined by whole genome sequencing versus phenotypic resistance in 234 Escherichia coli isolates.
Topics: Amikacin; Amoxicillin; Anti-Bacterial Agents; Cefepime; Cefotaxime; Ceftazidime; Ciprofloxacin; Clavulanic Acid; Escherichia coli; Escherichia coli Infections; Genotype; Gentamicins; Humans; Meropenem; Microbial Sensitivity Tests; Phenotype; Piperacillin; Retrospective Studies; Tazobactam; Tobramycin; Whole Genome Sequencing | 2023 |